AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Drug: belimumab
Target: Tumor necrosis factor ligand superfamily member 13B (Cytokine)
Gene: TNFSF13B
UniProt: Q9Y275 (TN13B_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: abciximab
Target: Integrin alpha-IIb/beta-3 (Adhesion)
Gene: ITGB3|ITGA2B
UniProt: P05106|P08514 (ITB3_HUMAN|ITA2B_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: ofatumumab
Target: B-lymphocyte antigen CD20 (Surface antigen)
Gene: MS4A1
UniProt: P11836 (CD20_HUMAN)
Organism: Homo sapiens
Activity: Kd = 9.92
Action type: ANTIBODY BINDING
Assay: Binding affinity for clone 2F2 ((HuMax-CD20).
Drug: canakinumab
Target: Interleukin-1 beta (Cytokine)
Gene: IL1B
UniProt: P01584 (IL1B_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: daclizumab
Target: Interleukin-2 receptor (Membrane receptor)
Gene: IL2RA|IL2RB|IL2RG
UniProt: P01589|P14784|P31785 (IL2RA_HUMAN|IL2RB_HUMAN|IL2RG_HUMAN)
Organism: Homo sapiens
Activity: Kd = 8
Action type: ANTIBODY BINDING
Drug: cetuximab
Target: Epidermal growth factor receptor (Kinase)
Gene: EGFR
UniProt: P00533 (EGFR_HUMAN)
Organism: Homo sapiens
Activity: Kd = 9.41
Action type: ANTIBODY BINDING
Drug: panitumumab
Target: Epidermal growth factor receptor (Kinase)
Gene: EGFR
UniProt: P00533 (EGFR_HUMAN)
Organism: Homo sapiens
Activity: Kd = 10.3
Action type: AGONIST
Drug: bevacizumab
Target: Vascular endothelial growth factor A (Secreted)
Gene: VEGFA
UniProt: P15692 (VEGFA_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: pertuzumab
Target: Receptor tyrosine-protein kinase erbB-2 (Kinase)
Gene: ERBB2
UniProt: P04626 (ERBB2_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Drug: ipilimumab
Target: Cytotoxic T-lymphocyte protein 4 (Surface antigen)
Gene: CTLA4
UniProt: P16410 (CTLA4_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Drug: efalizumab
Target: Leukocyte adhesion glycoprotein LFA-1 alpha (Adhesion)
Gene: ITGAL
UniProt: P20701 (ITAL_HUMAN)
Organism: Homo sapiens
Activity: Kd = 11.4
Action type: ANTIBODY BINDING
Assay: Binding of humanized MHM24 to human CD11a on Jurkat cells.
Drug: insulin degludec
Target: Insulin receptor (Kinase)
Gene: INSR
UniProt: P06213 (INSR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: raxibacumab
Target: Protective antigen (Secreted)
Gene: pagA
UniProt: P13423 (PAG_BACAN)
Organism: Bacillus anthracis
Activity: Kd = 8.556
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: brentuximab vedotin
Target: Tumor necrosis factor receptor superfamily member 8 (Membrane receptor)
Gene: TNFRSF8
UniProt: P28908 (TNR8_HUMAN)
Organism: Homo sapiens
Action type: BINDING AGENT
Assay: antibody binding to CD30-expressing cells
Drug: brentuximab vedotin
Target: Tubulin beta (Tumour-associated antigen)
Gene: TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
UniProt: P07437|Q9H4B7|Q13885|Q9BVA1|Q13509|P04350|P68371|Q9BUF5|Q3ZCM7 (TBB5_HUMAN|TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB6_HUMAN|TBB8_HUMAN)
Organism: Homo sapiens
Action type: INHIBITOR
Assay: microtubule disrupting agent auristatin E
Drug: denosumab
Target: Tumor necrosis factor ligand superfamily member 11 (Cytokine)
Gene: TNFSF11
UniProt: O14788 (TNF11_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: ustekinumab
Target: Interleukin-12 (Cytokine)
Gene: IL12A|IL12B
UniProt: P29459|P29460 (IL12A_HUMAN|IL12B_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: ustekinumab
Target: Interleukin-23 (Cytokine)
Gene: IL12B|IL23A
UniProt: P29460|Q9NPF7 (IL12B_HUMAN|IL23A_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: golimumab
Target: Tumor necrosis factor (Cytokine)
Gene: TNF
UniProt: P01375 (TNFA_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: certolizumab pegol
Target: Tumor necrosis factor (Cytokine)
Gene: TNF
UniProt: P01375 (TNFA_HUMAN)
Organism: Homo sapiens
Activity: Kd = 10.046
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: eculizumab
Target: Complement C5 (Secreted)
Gene: C5
UniProt: P01031 (CO5_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: natalizumab
Target: Integrin alpha-4/beta-1 (Adhesion)
Gene: ITGA4|ITGB1
UniProt: P13612|P05556 (ITA4_HUMAN|ITB1_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: natalizumab
Target: Integrin alpha-4/beta-7 (Adhesion)
Gene: ITGA4|ITGB7
UniProt: P13612|P26010 (ITA4_HUMAN|ITB7_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: ranibizumab
Target: Vascular endothelial growth factor A (Secreted)
Gene: VEGFA
UniProt: P15692 (VEGFA_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: omalizumab
Target: Ig epsilon chain C region (Antibody)
Gene: IGHE
UniProt: P01854 (IGHE_HUMAN)
Organism: Homo sapiens
Activity: Kd = 8.16
Action type: ANTIBODY BINDING
Assay: <i>In vitro</i> binding affinity
Drug: chidamide
Target: Nicotinamide phosphoribosyltransferase (Enzyme)
Gene: NAMPT
UniProt: P43490 (NAMPT_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.68
Assay: Inhibition of human NAMPT using NAM and PRPP as substrates incubated for 90 mins in presence of NMNAT by fluorometric method
Drug: chidamide
Target: Nicotinamide phosphoribosyltransferase (Cytokine)
Gene: NAMPT
UniProt: P43490 (NAMPT_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.68
Assay: Inhibition of human NAMPT using NAM and PRPP as substrates incubated for 90 mins in presence of NMNAT by fluorometric method
Drug: chidamide
Target: Histone deacetylase 8 (Enzyme)
Gene: HDAC8
UniProt: Q9BY41 (HDAC8_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.135
Action type: INHIBITOR
Assay: HDAC enzyme inhibition assay using BSA substrate
Drug: chidamide
Target: Histone deacetylase 11 (Enzyme)
Gene: HDAC11
UniProt: Q96DB2 (HDA11_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.365
Action type: INHIBITOR
Assay: HDAC enzyme inhibition assay using BSA substrate
Drug: chidamide
Target: Histone deacetylase 2 (Enzyme)
Gene: HDAC2
UniProt: Q92769 (HDAC2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.796
Action type: INHIBITOR
Assay: HDAC enzyme inhibition assay using BSA substrate
Drug: chidamide
Target: Histone deacetylase 1 (Enzyme)
Gene: HDAC1
UniProt: Q13547 (HDAC1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.022
Action type: INHIBITOR
Assay: HDAC enzyme inhibition assay using BSA substrate
Drug: chidamide
Target: Histone deacetylase 3 (Enzyme)
Gene: HDAC3
UniProt: O15379 (HDAC3_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.174
Action type: INHIBITOR
Assay: HDAC enzyme inhibition assay using BSA substrate
Drug: chidamide
Target: Histone deacetylase 10 (Enzyme)
Gene: HDAC10
UniProt: Q969S8 (HDA10_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.108
Action type: INHIBITOR
Assay: HDAC enzyme inhibition assay using BSA substrate
Drug: infliximab
Target: Tumor necrosis factor (Cytokine)
Gene: TNF
UniProt: P01375 (TNFA_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Drug: rituximab
Target: B-lymphocyte antigen CD20 (Surface antigen)
Gene: MS4A1
UniProt: P11836 (CD20_HUMAN)
Organism: Homo sapiens
Activity: Kd = 8.51
Action type: ANTIBODY BINDING
Drug: triamcinolone hexacetonide
Target: Glucocorticoid receptor (Nuclear hormone receptor)
Gene: NR3C1
UniProt: P04150 (GCR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: siltuximab
Target: Interleukin-6 (Cytokine)
Gene: IL6
UniProt: P05231 (IL6_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: etanercept
Target: Tumor necrosis factor (Cytokine)
Gene: TNF
UniProt: P01375 (TNFA_HUMAN)
Organism: Homo sapiens
Action type: INHIBITOR
Assay: Mechanism of Action
Drug: trastuzumab
Target: Receptor tyrosine-protein kinase erbB-2 (Kinase)
Gene: ERBB2
UniProt: P04626 (ERBB2_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: gemtuzumab ozogamicin
Target: Myeloid cell surface antigen CD33 (Surface antigen)
Gene: CD33
UniProt: P20138 (CD33_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: insulin aspart
Target: Insulin receptor (Kinase)
Gene: INSR
UniProt: P06213 (INSR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: vedolizumab
Target: Integrin alpha-4/beta-7 (Adhesion)
Gene: ITGA4|ITGB7
UniProt: P13612|P26010 (ITA4_HUMAN|ITB7_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.3
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: obinutuzumab
Target: B-lymphocyte antigen CD20 (Surface antigen)
Gene: MS4A1
UniProt: P11836 (CD20_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: ibritumomab tiuxetan
Target: B-lymphocyte antigen CD20 (Surface antigen)
Gene: MS4A1
UniProt: P11836 (CD20_HUMAN)
Organism: Homo sapiens
Activity: Kd = 7.854
Action type: ANTIBODY BINDING
Assay: Mechanism of Action
Drug: insulin detemir
Target: Insulin receptor (Kinase)
Gene: INSR
UniProt: P06213 (INSR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: pegfilgrastim
Target: Granulocyte colony-stimulating factor receptor (Membrane receptor)
Gene: CSF3R
UniProt: Q99062 (CSF3R_HUMAN)
Organism: Homo sapiens
Action type: ACTIVATOR
Assay: Mechanism of Action
Drug: filgrastim
Target: Granulocyte colony-stimulating factor receptor (Membrane receptor)
Gene: CSF3R
UniProt: Q99062 (CSF3R_HUMAN)
Organism: Homo sapiens
Action type: ACTIVATOR
Assay: Mechanism of Action
Drug: deoxycholic acid
Target: fMet-Leu-Phe receptor (GPCR)
Gene: FPR1
UniProt: P21462 (FPR1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 4
Action type: ANTAGONIST
Drug: deoxycholic acid
Target: Bile acid receptor (Nuclear hormone receptor)
Gene: NR1H4
UniProt: Q96RI1 (NR1H4_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 4.35
Assay: Agonist activity at GST-tagged FXR-LBD (unknown origin) assessed as biotin-labeled SRC-1 recruitment after 30 mins by Alpha Screen assay
Drug: deoxycholic acid
Target: G-protein coupled bile acid receptor 1 (GPCR)
Gene: GPBAR1
UniProt: Q8TDU6 (GPBAR_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 6.2
Action type: AGONIST
Drug: deoxycholic acid
Target: Steroid Delta-isomerase (Unclassified)
Gene: ksi
UniProt: P07445 (SDIS_PSEPU)
Organism: Pseudomonas putida
Activity: Kd = 4.8
Drug: trastuzumab emtansine
Target: Receptor tyrosine-protein kinase erbB-2 (Kinase)
Gene: ERBB2
UniProt: P04626 (ERBB2_HUMAN)
Organism: Homo sapiens
Action type: ANTIBODY BINDING
Assay: binding to sub-domain IV of the HER2 receptor
Drug: trastuzumab emtansine
Target: Tubulin beta (Tumour-associated antigen)
Gene: TUBB|TUBB1|TUBB2A|TUBB2B|TUBB3|TUBB4A|TUBB4B|TUBB6|TUBB8
UniProt: P07437|Q9H4B7|Q13885|Q9BVA1|Q13509|P04350|P68371|Q9BUF5|Q3ZCM7 (TBB5_HUMAN|TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB6_HUMAN|TBB8_HUMAN)
Organism: Homo sapiens
Action type: INHIBITOR
Assay: microtubule destabilizing agent maytansine derivative
Drug: lipegfilgrastim
Target: Granulocyte colony-stimulating factor receptor (Membrane receptor)
Gene: CSF3R
UniProt: Q99062 (CSF3R_HUMAN)
Organism: Homo sapiens
Action type: ACTIVATOR
Assay: Mechanism of Action
Drug: vonoprazan
Target: Potassium-transporting ATPase (Transporter)
Gene: ATP4A|ATP4B
UniProt: P20648|P51164 (ATP4A_HUMAN|ATP4B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8
Action type: INHIBITOR
Assay: [14C]TAK-438 binding
Drug: epoetin alfa
Target: Erythropoietin receptor (Membrane receptor)
Gene: EPOR
UniProt: P19235 (EPOR_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 11.15
Action type: AGONIST
Assay: Assay performed using recombinant human EPO
Drug: romiplostim
Target: Thrombopoietin receptor (Membrane receptor)
Gene: MPL
UniProt: P40238 (TPOR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: evolocumab
Target: Proprotein convertase subtilisin/kexin type 9 (Enzyme)
Gene: PCSK9
UniProt: Q8NBP7 (PCSK9_HUMAN)
Organism: Homo sapiens
Activity: Kd = 9.72
Action type: INHIBITOR
Assay: Dissociation equilibrium constant for wild-type hPCSK9, measured using proprietary BIACore&reg; technology.
Drug: eluxadoline
Target: Mu-type opioid receptor (GPCR)
Gene: Oprm1
UniProt: P33535 (OPRM_RAT)
Organism: Rattus norvegicus
Activity: Ki = 9.05
Drug: eluxadoline
Target: Delta-type opioid receptor (GPCR)
Gene: Oprd1
UniProt: P33533 (OPRD_RAT)
Organism: Rattus norvegicus
Activity: Ki = 8.89
Drug: eluxadoline
Target: Kappa-type opioid receptor (GPCR)
Gene: OPRK1
UniProt: P41145 (OPRK_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.26
Action type: AGONIST
Assay: Recombinantly expressed human kappa OR
Drug: eluxadoline
Target: Kappa-type opioid receptor (GPCR)
Gene: OPRK1
UniProt: P41144 (OPRK_CAVPO)
Organism: Cavia porcellus
Activity: Ki = 7.26
Action type: AGONIST
Drug: eluxadoline
Target: Mu-type opioid receptor (GPCR)
Gene: OPRM1
UniProt: P35372 (OPRM_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.77
Action type: AGONIST
Assay: Recombinantly expressed human mu OR
Drug: eluxadoline
Target: Delta-type opioid receptor (GPCR)
Gene: OPRD1
UniProt: P41143 (OPRD_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.886
Action type: ANTAGONIST
Assay: equivalent to DPDPE in human SK-N-BE cells
Drug: insulin lispro
Target: Insulin receptor (Kinase)
Gene: INSR
UniProt: P06213 (INSR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: insulin human
Target: Tyrosine-protein kinase Lck (Kinase)
Gene: LCK
UniProt: P06239 (LCK_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.74
Assay: DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))
Drug: insulin human
Target: Insulin receptor (Kinase)
Gene: Insr
UniProt: P15127 (INSR_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 8.71
Drug: insulin human
Target: Insulin receptor (Kinase)
Gene: INSR
UniProt: P06213 (INSR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: mirodenafil
Target: cGMP-specific 3',5'-cyclic phosphodiesterase (Enzyme)
Gene: PDE5A
UniProt: O76074 (PDE5A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 9.469
Action type: INHIBITOR
Assay: Mechanism of Action
Drug: cangrelor
Target: P2Y purinoceptor 13 (GPCR)
Gene: P2RY13
UniProt: Q9BPV8 (P2Y13_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.3
Action type: ANTAGONIST
Drug: cangrelor
Target: Uracil nucleotide/cysteinyl leukotriene receptor (GPCR)
Gene: Gpr17
UniProt: Q6NS65 (GPR17_MOUSE)
Organism: Mus musculus
Activity: IC50 = 8.92
Action type: ANTAGONIST
Drug: cangrelor
Target: P2Y purinoceptor 12 (GPCR)
Gene: P2RY12
UniProt: Q9H244 (P2Y12_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.627
Action type: ANTAGONIST
Assay: cAMP accumulation in HORK3-expressing cells
Drug: epoetin theta
Target: Erythropoietin receptor (Membrane receptor)
Gene: EPOR
UniProt: P19235 (EPOR_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: sonidegib
Target: Sonic hedgehog protein (Enzyme)
Gene: Shh
UniProt: Q62226 (SHH_MOUSE)
Organism: Mus musculus
Activity: IC50 = 8.26
Drug: sonidegib
Target: Smoothened homolog (GPCR)
Gene: SMO
UniProt: Q99835 (SMO_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.222
Action type: ANTAGONIST
Drug: mecasermin
Target: Insulin receptor (Kinase)
Gene: INSR
UniProt: P06213 (INSR_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.854
Assay: human placental insulin receptor
Drug: mecasermin
Target: Insulin-like growth factor 1 receptor (Kinase)
Gene: IGF1R
UniProt: P08069 (IGF1R_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.31
Action type: AGONIST
Assay: human placental type 1 IGF receptor
Drug: lumacaftor
Target: Cystic fibrosis transmembrane conductance regulator (Ion channel)
Gene: CFTR
UniProt: P13569 (CFTR_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 6.456
Action type: PHARMACOLOGICAL CHAPERONE
Assay: human bronchial epithelial (HBE) cells with CF homozygous for the F508del CFTR mutation
Drug: aldesleukin
Target: Interleukin-2 receptor (Membrane receptor)
Gene: IL2RA|IL2RB|IL2RG
UniProt: P01589|P14784|P31785 (IL2RA_HUMAN|IL2RB_HUMAN|IL2RG_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action
Drug: sacubitril
Target: Neprilysin (Enzyme)
Gene: MME
UniProt: P08473 (NEP_HUMAN)
Organism: Homo sapiens
Action type: INHIBITOR
Drug: trelagliptin
Target: Dipeptidyl peptidase 4 (Enzyme)
Gene: DPP4
UniProt: P27487 (DPP4_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.398
Action type: INHIBITOR
Drug: brexpiprazole
Target: D(2) dopamine receptor (GPCR)
Gene: Drd2
UniProt: P61169 (DRD2_RAT)
Organism: Rattus norvegicus
Activity: Ki = 9.7
Assay: Dopamine D2 Receptor Binding Assay: The assay was performed according to the method by Kohler et al. (Kohler C, Hall H, Ogren S O and Gawell L, Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem. Pharmacol., 1985 34: 2251-2259). The binding assay was performed using 40 ul of the membrane specimen, 20 ul of [3H]-raclopride (final concentration 1 to 2 nM), 20 ul of a test drug and 50 mM Tris-hydrochloric acid buffer (containing 120 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, pH 7.4) so that the total amount was 200 ul (final dimethylsulfoxide concentration 1%). The reaction was performed at room temperature for 1 hour and terminated by conducting suction filtration with a cell harvester on a glass fiber filter plate. The filter plate made of glass fiber was washed with 50 mM Tris-hydrochloric acid buffer (pH 7.4), and after dried, a microplate liquid scintillation coc
Drug: brexpiprazole
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: Htr1a
UniProt: P19327 (5HT1A_RAT)
Organism: Rattus norvegicus
Activity: Ki = 10.05
Assay: Displacement of [3H]-8-OH-DPAT from 5HT1A receptor in rat brain hippocampus incubated for 60 mins by radioligand binding assay
Drug: brexpiprazole
Target: 5-hydroxytryptamine receptor 2A (GPCR)
Gene: Htr2a
UniProt: P14842 (5HT2A_RAT)
Organism: Rattus norvegicus
Activity: Ki = 8.64
Assay: Serotonin 5-HT2A Receptor Binding Assay: The assay was performed according to the method by Leysen J E et al. (Leysen J E, Niemegeers C J E, Van Nueten J M and Laduron P M. [3H] Ketanserin (R 41 468), a selective 3H-ligand for serotonin 2 receptor binding sites. Mol. Pharmacol., 1982, 21: 301-314). The binding assay was performed using 40 ul of the membrane specimen, 20 ul of [3H]-Ketanserin (final concentration 1 to 3 nM), 20 ul of a test drug and 50 mM Tris-hydrochloric acid buffer (pH 7.4) so that the total amount was 200 ul (final dimethylsulfoxide concentration 1%). The reaction was performed at 37° C. for 20 minutes and terminated by conducting suction filtration with a cell harvester on a glass fiber filter plate.The filter plate made of glass fiber was washed with 50 mM Tris-hydrochloric acid buffer (pH 7.4), and after dried, a microplate liquid scintillation cocktail was added and the radioactivity was measured with a microplate scintillation counter.
Drug: brexpiprazole
Target: Beta-1 adrenergic receptor (GPCR)
Gene: ADRB1
UniProt: P08588 (ADRB1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.229
Drug: brexpiprazole
Target: Beta-2 adrenergic receptor (GPCR)
Gene: ADRB2
UniProt: P07550 (ADRB2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.174
Drug: brexpiprazole
Target: D(1A) dopamine receptor (GPCR)
Gene: DRD1
UniProt: P21728 (DRD1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.796
Action type: AGONIST
Drug: brexpiprazole
Target: Alpha-2A adrenergic receptor (GPCR)
Gene: ADRA2A
UniProt: P08913 (ADA2A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.824
Drug: brexpiprazole
Target: Sodium-dependent serotonin transporter (Transporter)
Gene: SLC6A4
UniProt: P31645 (SC6A4_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 7.538
Action type: INHIBITOR
Drug: brexpiprazole
Target: Sodium-dependent noradrenaline transporter (Transporter)
Gene: SLC6A2
UniProt: P23975 (SC6A2_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.857
Action type: INHIBITOR
Drug: brexpiprazole
Target: 5-hydroxytryptamine receptor 2B (GPCR)
Gene: HTR2B
UniProt: P41595 (5HT2B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.721
Action type: ANTAGONIST
Drug: brexpiprazole
Target: 5-hydroxytryptamine receptor 2C (GPCR)
Gene: HTR2C
UniProt: P28335 (5HT2C_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.469
Drug: brexpiprazole
Target: 5-hydroxytryptamine receptor 6 (GPCR)
Gene: HTR6
UniProt: P50406 (5HT6R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.237
Drug: brexpiprazole
Target: 5-hydroxytryptamine receptor 7 (GPCR)
Gene: HTR7
UniProt: P34969 (5HT7R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.432
Action type: ANTAGONIST
Drug: brexpiprazole
Target: Alpha-1A adrenergic receptor (GPCR)
Gene: ADRA1A
UniProt: P35348 (ADA1A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.42
Drug: brexpiprazole
Target: Alpha-2B adrenergic receptor (GPCR)
Gene: ADRA2B
UniProt: P18089 (ADA2B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.77
Drug: brexpiprazole
Target: D(3) dopamine receptor (GPCR)
Gene: DRD3
UniProt: P35462 (DRD3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.959
Action type: AGONIST
Drug: brexpiprazole
Target: Histamine H1 receptor (GPCR)
Gene: HRH1
UniProt: P35367 (HRH1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.721
Action type: ANTAGONIST
Drug: brexpiprazole
Target: 5-hydroxytryptamine receptor 1B (GPCR)
Gene: HTR1B
UniProt: P28222 (5HT1B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.495
Drug: brexpiprazole
Target: Alpha-2C adrenergic receptor (GPCR)
Gene: ADRA2C
UniProt: P18825 (ADA2C_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.229
Action type: ANTAGONIST
Drug: brexpiprazole
Target: Sodium-dependent dopamine transporter (Transporter)
Gene: SLC6A3
UniProt: Q01959 (SC6A3_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.025
Action type: INHIBITOR
Drug: brexpiprazole
Target: D(4) dopamine receptor (GPCR)
Gene: DRD4
UniProt: P21917 (DRD4_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.201
Action type: AGONIST
Drug: brexpiprazole
Target: Alpha-1D adrenergic receptor (GPCR)
Gene: ADRA1D
UniProt: P25100 (ADA1D_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.585
Action type: ANTAGONIST
Drug: brexpiprazole
Target: Alpha-1B adrenergic receptor (GPCR)
Gene: ADRA1B
UniProt: P35368 (ADA1B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.77
Action type: ANTAGONIST
Drug: brexpiprazole
Target: 5-hydroxytryptamine receptor 5A (GPCR)
Gene: HTR5A
UniProt: P47898 (5HT5A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.854
Drug: brexpiprazole
Target: D(2) dopamine receptor (GPCR)
Gene: DRD2
UniProt: P14416 (DRD2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.523
Action type: AGONIST
Drug: brexpiprazole
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: HTR1A
UniProt: P08908 (5HT1A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.921
Action type: AGONIST
Drug: brexpiprazole
Target: 5-hydroxytryptamine receptor 2A (GPCR)
Gene: HTR2A
UniProt: P28223 (5HT2A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.328
Action type: ANTAGONIST
Drug: pegvisomant
Target: Growth hormone receptor (GPCR)
Gene: GHR
UniProt: P10912 (GHR_HUMAN)
Organism: Homo sapiens
Action type: ANTAGONIST
Assay: Mechanism of Action
Drug: alirocumab
Target: Proprotein convertase subtilisin/kexin type 9 (Enzyme)
Gene: PCSK9
UniProt: Q8NBP7 (PCSK9_HUMAN)
Organism: Homo sapiens
Activity: Kd = 9.42
Action type: INHIBITOR
Drug: anakinra
Target: Interleukin-1 receptor, type I (Membrane receptor)
Gene: IL1R1|IL1RAP
UniProt: P14778|Q9NPH3 (IL1R1_HUMAN|IL1AP_HUMAN)
Organism: Homo sapiens
Activity: Kd = 7.82
Action type: ANTAGONIST
Assay: Mechanism of Action
Drug: flibanserin
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: Htr1a
UniProt: P19327 (5HT1A_RAT)
Organism: Rattus norvegicus
Activity: Ki = 7.93
Assay: Binding affinity to 5HT1A receptor in rat cortex membrane
Drug: flibanserin
Target: D(2) dopamine receptor (GPCR)
Gene: DRD2
UniProt: P14416 (DRD2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.516
Drug: flibanserin
Target: D(3) dopamine receptor (GPCR)
Gene: DRD3
UniProt: P35462 (DRD3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.439